Risk of cancer in patients exposed to gabapentin in two electronic medical record systems
Pharmacoepidemiology and Drug Safety, 12/23/2011
Irizarry MC et al. – The epidemiological data in a US cohort with up to 12years of follow–up and a UK cohort with up to 15years of follow–up do not support a carcinogenic effect of gabapentin use. However, the confidence intervals for some analyses were wide, and an important effect cannot be confidently excluded.






